Anika Therapeutics, Inc. (ANIK) Debt Components
- 2020-09-30: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $25.00M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2020-06-30: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $50.00M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2019-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $0.00; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2013-09-30: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
Anika Therapeutics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Debt Instrument, Basis Spread on Variable Rate pure | Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) pure | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-09-30 | (m) | $25.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $50.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · 1.25% | (m) | (m) |
| 2013-09-30 | $1.60M | $6.80M | $8.40M | (m) | (m) | (m) | (m) | (m) | 1.43% | (m) |
| 2013-06-30 | $1.60M | $7.20M | $8.80M | (m) | (m) | (m) | (m) | (m) | 1.48% | (m) |
| 2013-03-31 | $1.60M | $7.60M | $9.20M | (m) | (m) | (m) | (m) | (m) | 1.53% | (m) |
| 2012-12-31 | $1.60M | $8.00M | $9.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | $1.60M | $1.60M | $6.40M | $6.40M | (m) | (m) | (m) |
| 2012-09-30 | $1.60M | $8.40M | $10.00M | (m) | (m) | (m) | (m) | (m) | 1.64% | (m) |
| 2012-06-30 | $1.60M | $8.80M | $10.40M | (m) | (m) | (m) | (m) | (m) | 1.72% | (m) |
| 2012-03-31 | $1.60M | $9.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $1.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $9.60M | $11.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | $1.60M | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $1.60M | $10.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $1.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $11.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $16.00M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |